Gene · 80339
Papers3,957
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,957
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Triglyceride glucose-waist circumference: the optimum index to screen nonalcoholic fatty liver disease in non-obese adults. | BMC Gastroenterol | 2023 | 37919650 | PubTator, text mining | PubMed |
| QnAs with Helen H. Hobbs and Jonathan C. Cohen. | Proc Natl Acad Sci U S A | 2023 | 37910553 | PubTator, text mining | PubMed |
| The PNPLA3 I148M variant increases ketogenesis and decreases hepatic de novo lipogenesis and mitochondrial function in humans. | Cell Metab | 2023 | 37909034 | PubTator, text mining | PubMed |
| Genome-wide association analysis of plasma lipidome identifies 495 genetic associations. | Nat Commun | 2023 | 37907536 | PubTator, text mining | PubMed |
| Clinical Classification of Obesity and Implications for Metabolic Dysfunction-Associated Fatty Liver Disease and Treatment. | Diabetes Metab Syndr Obes | 2023 | 37905232 | PubTator, text mining | PubMed |
| An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver disease. | Nat Med | 2023 | 37903863 | PubTator, text mining | PubMed |
| PNPLA3 rs738409 Genetic Variant Inversely Correlates with Platelet Count, Thereby Affecting the Performance of Noninvasive Scores of Hepatic Fibrosis. | Int J Mol Sci | 2023 | 37894727 | PubTator, text mining | PubMed |
| Gene Variants Implicated in Steatotic Liver Disease: Opportunities for Diagnostics and Therapeutics. | Biomedicines | 2023 | 37893185 | PubTator, text mining | PubMed |
| Genome, Metabolism, or Immunity: Which Is the Primary Decider of Pancreatic Cancer Fate through Non-Apoptotic Cell Death? | Biomedicines | 2023 | 37893166 | PubTator, text mining | PubMed |
| Pathology and Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatic Tumors. | Biomedicines | 2023 | 37893134 | PubTator, text mining | PubMed |
| Biomarkers for Assessing Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus on Sodium-Glucose Cotransporter 2 Inhibitor Therapy. | J Clin Med | 2023 | 37892698 | PubTator, text mining | PubMed |
| Personalized Risk Assessment of Hepatic Fibrosis after Cholecystectomy in Metabolic-Associated Steatotic Liver Disease: A Machine Learning Approach. | J Clin Med | 2023 | 37892625 | PubTator, text mining | PubMed |
| The Surreptitious Burden of Nonalcoholic Fatty Liver Disease in the Elderly in the Asia-Pacific Region: An Insight from the Global Burden of Disease Study 2019. | J Clin Med | 2023 | 37892594 | PubTator, text mining | PubMed |
| MicroRNAs Signature Panel Identifies Heavy Drinkers with Alcohol-Associated Cirrhosis from Heavy Drinkers without Liver Injury. | Biology (Basel) | 2023 | 37887024 | PubTator, text mining | PubMed |
| White Adipose Tissue Heterogeneity in the Single-Cell Era: From Mice and Humans to Cattle. | Biology (Basel) | 2023 | 37886999 | PubTator, text mining | PubMed |
| Multi-ancestry Polygenic Mechanisms of Type 2 Diabetes Elucidate Disease Processes and Clinical Heterogeneity. | Res Sq | 2023 | 37886436 | PubTator, text mining | PubMed |
| Practice guidance documents for the diagnosis and management of non-alcoholic fatty liver disease-recent updates and open questions. | Hepatobiliary Surg Nutr | 2023 | 37886211 | PubTator, text mining | PubMed |
| Inflammatory signaling in NASH driven by hepatocyte mitochondrial dysfunctions. | J Transl Med | 2023 | 37884933 | PubTator, text mining | PubMed |
| Gene profiles and mutations in the development of cataracts in the ICR rat model of hereditary cataracts. | Sci Rep | 2023 | 37875594 | PubTator, text mining | PubMed |
| The fatty liver disease-causing protein PNPLA3-I148M alters lipid droplet-Golgi dynamics. | bioRxiv | 2023 | 37873239 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80339/papers?page=28